This kit supplies reagents sufficient to make 5 recombinant adenoviral vectors.
The gene to be expressed is inserted into the multiple cloning site of pLEP-CMV,
and the plasmid is then cut with a restriction enzyme (PI-Psp I) and ligated to pREP,
which contains the remainder of the adenoviral genome.
Two versions of the kit are available, one with pREP and the other with pREP-E3.
Vectors made with pREP can accommodate inserts up to 5 kb, whereas those made with pREP-E3
can accommodate longer inserts (up to 8 kb). The additional capacity is due to deletion of
the adenoviral E3 genes. The E3 genes reduce host immune responses to viral infection, but
they are not required for viral propagation. We recommend using pREP whenever possible.
The pREP plasmid has been linearized and is ready to be ligated to the pLEP-CMV plasmid.
The CMV promoter provides high levels of gene expression in most tissues and cell types.
The human growth hormone polyadenylation sequence is used for gene expression.
For those who would like to use promoter of their choice along with their gene,
we recommend using the pLEP vector (no promoter, no poplyA signal) instead of pLEP-CMV
(see K1000 SpeAdTM kit). The manual that accompanies the kit provides detailed
instructions for making adenoviral vectors using the SpeAdTM method.
Kit includes: pLEP-CMV (20 ug)
pREP7 (or 8), linearized
(10 ug)
positive
control plasmid to express b-galactosidase
(10 ug)
lambda
phage packaging extract (5 x 50 ml)
phage
dilution buffer (3 ml)
ready-to-use
bacterial host (E coli DK-1 cells, 1 ml)
sequencing
primers (2, 100 ng each)
SpeAdTM
Manual